Literature DB >> 11786096

Down-regulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis.

Tadashi Sato1, Kaihui Liang, Nosratola D Vaziri.   

Abstract

BACKGROUND: Patients and animals with nephrotic syndrome and those with chronic renal failure (CRF) often exhibit hypertriglyceridemia and impaired very low-density lipoprotein (VLDL) clearance. Imai rats that were originally derived from Sprague-Dawley rats develop spontaneous proteinuria, hyperlipidemia, progressive renal insufficiency and histologic changes of focal glomerulosclerosis (FGS), closely resembling human FGS. This study was undertaken to test the hypothesis that elevation of plasma triglyceride and VLDL concentrations in the Imai rats is associated with deficiency of lipoprotein lipase (LPL) and VLDL receptor which are the main pathways of triglyceride-rich lipoprotein clearance.
METHODS: Male Imai and Sprague-Dawley control rats were fed regular rat chow and studied at 10 and 34 weeks of age. Tissue LPL and VLDL-r protein abundance (Western analysis) and post-heparin lipolytic activity were determined.
RESULTS: At 10 weeks of age, Imai rats showed mild proteinuria, moderate hyperlipidemia, normal creatinine clearance and blood pressure. By 34 weeks of age, the study animal exhibited severe proteinuria, marked hyperlipidemia, significant renal insufficiency and hypertension. This was associated with a severe progressive reduction in skeletal muscle and adipose tissue LPL and VLDL-r protein abundance and depressed plasma post heparin, lipolytic activity.
CONCLUSION: Progressive hyperlipidemia in the Imai rats with spontaneous FGS is accompanied by severe combined LPL and VLDL-r deficiencies that can, in part, account for the associated hypertriglyceridemia and elevated plasma VLDL concentrations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786096     DOI: 10.1046/j.1523-1755.2002.00104.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

Review 1.  Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease.

Authors:  Nosratola D Vaziri
Journal:  Clin Exp Nephrol       Date:  2013-08-24       Impact factor: 2.801

2.  Impaired postprandial lipemic response in chronic kidney disease.

Authors:  Jeffrey M Saland; Lisa M Satlin; Jeanna Zalsos-Johnson; Serge Cremers; Henry N Ginsberg
Journal:  Kidney Int       Date:  2016-05-07       Impact factor: 10.612

Review 3.  Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.

Authors:  Nosratola D Vaziri
Journal:  Kidney Int       Date:  2016-04-26       Impact factor: 10.612

4.  Glomerular Lesions in Proteinuric Miniature Schnauzer Dogs.

Authors:  E Furrow; G E Lees; C A Brown; R E Cianciolo
Journal:  Vet Pathol       Date:  2016-12-22       Impact factor: 2.221

5.  Hyperlipidaemia in trypanosomiasis of naturally infected horses: possible cachexia-anorexia syndrome?

Authors:  Muthusamy Ranjithkumar; Tauseef Ahmed Malik; Anju Saxena; Ananya Dan; Pillanatham Civalingam Sakthivel; Sahadeb Dey
Journal:  Trop Anim Health Prod       Date:  2012-07-27       Impact factor: 1.559

6.  Quantitative trait loci for urinary albumin in crosses between C57BL/6J and A/J inbred mice in the presence and absence of Apoe.

Authors:  Carolien Doorenbos; Shirng-Wern Tsaih; Susan Sheehan; Naoki Ishimori; Gerjan Navis; Gary Churchill; Keith Dipetrillo; Ron Korstanje
Journal:  Genetics       Date:  2008-05       Impact factor: 4.562

7.  Expression profiling of hepatic genes associated with lipid metabolism in nephrotic rats.

Authors:  Yunfeng Zhou; Xiaoyan Zhang; Lihong Chen; Jing Wu; Huaixin Dang; Mingfen Wei; Yanbo Fan; Yahua Zhang; Yi Zhu; Nanping Wang; Matthew D Breyer; Youfei Guan
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-09

Review 8.  HDL abnormalities in nephrotic syndrome and chronic kidney disease.

Authors:  Nosratola D Vaziri
Journal:  Nat Rev Nephrol       Date:  2015-11-16       Impact factor: 28.314

9.  Proteinuria and lipoprotein lipase activity in Miniature Schnauzer dogs with and without hypertriglyceridemia.

Authors:  E Furrow; J Q Jaeger; V J Parker; K W Hinchcliff; S E Johnson; S J Murdoch; I H de Boer; R G Sherding; J D Brunzell
Journal:  Vet J       Date:  2016-04-20       Impact factor: 2.688

10.  Hepatic fatty acid and cholesterol metabolism in nephrotic syndrome.

Authors:  Seungyeup Han; Nosratola D Vaziri; Pavan Gollapudi; Vincent Kwok; Hamid Moradi
Journal:  Am J Transl Res       Date:  2013-03-28       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.